SODIUM THIOSULFATE | N212937 | FENNEC PHARMACEUTICALS INC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2022-00123 | 10596190 | IPR | Hope Medical Enterprises, Inc. | Final Written Decision | 2021-10-29 | 2023-04-18 |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
FENNEC PHARMACEUTICALS, INC. v. CIPLA LIMITED et al 3 patentsANDA 218028sodium thiosulfate | D.N.J. | 2025-05-27 | Terminated 2025-07-14 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition From Hope Pharmaceuticals FDA-2014-P-0916 · 6 docket documents Hope Pharmaceuticals filed this citizen petition pursuant to sections 505(b) and 505(j) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA not approve any new applications for sodium nitrite and sodium thiosulfate drug products unless applicants meet or exceed the heightened purity | 505(q) | 2014-07-02 | Denied | Hope Pharmaceuticals |
Source: Regulations.gov. FDA citizen petitions matched by application number.
| Code | Date | Status |
|---|---|---|
| ODE-384 | Sep 20, 2029 | Active |